Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites

NCT00908219 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00908219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00908219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2009
Completion date
February 28, 2011
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malignant ascites